7.01 USD
▲+1.31+22.98%
盘后 6.00 0.00%
2026-09-16
市值
$87.15M
市盈率
—
EPS
-0.78
股息率
—
52 周区间
2.21 – 9.33
成交量
962.62K
Beta
1.45
目标价
11.00
52W 低 2.2152W 高 9.33
价格走势
公司简介
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation di...